Psoriasis Completed Phase 1 Trials for Methotrexate (DB00563)

Also known as: PSORIASIS / Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02097173Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen